1547. Activity of Tedizolid and Comparator Agents against Gram-Positive Bacterial Isolates Causing Skin and Skin Structure Infections in Pediatric Patients during 2015-2019 in the US

BACKGROUND: New strategies to treat acute bacterial skin and skin structure infections (ABSSSI) are needed due to the spread of methicillin-resistant Staphylococcus aureus (MRSA), a common multidrug resistant pathogen of ABSSSIs. Tedizolid (TZD) was approved by the US FDA for treating ABSSSI in adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalhaes, Cecilia G, Sader, Helio S, Rhomberg, Paul R, Castanheira, Mariana, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777891/
http://dx.doi.org/10.1093/ofid/ofaa439.1727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777891/
http://dx.doi.org/10.1093/ofid/ofaa439.1727

Ejemplares similares